Peace Lilies are one of the most popular house plants available, and it's little wonder why thanks to their incredibly beauty ...

After spending many years abroad, Anil finally gave life to his long-cherished dream of farming on a small plot beside his ...

Eli Lilly stock has soared in the triple digits over three years. Investors are excited about the company’s portfolio of weight loss drugs, which has generated blockbuster revenue. The stock recently ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Sheldon ISD, whose ...

Eli Lilly & Co.’s stock has reached new highs in recent days, becoming the first pharmaceutical company to hit a $1 trillion valuation. The surge has also lifted the founding family’s private ...

A fresh call from Bernstein has Wall Street doing a double-take. Bernstein just reset Eli Lilly’s price target. Analyst Breen cites talks about GLP-1 catalysts, robust U.S. policy, and promising ...

Philadelphia is about to become the host of the fifth Lilly Gateway Labs, a biotech incubator for early-stage companies backed by Eli Lilly & Co., writes Harold Brubaker for The Philadelphia Inquirer.

LillyDirect is a legitimate, direct-to-consumer platform that offers authentic Eli Lilly medication. This platform accepts insurance and offers self-pay options. LillyDirect is partnered with licensed ...

Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them just a few years in. Eli Lilly is rewriting the rules of pharma. Not only did ...

Eli Lilly’s stock (NYSE: LLY) soared nearly 50%, in the past six months, driven not only by outstanding earnings and a notable margin increase, but also by reaching a $1T market cap and excitement ...

Eli Lilly is upgraded to a "Strong Buy" due to 54% revenue growth, driven by Zepbound and Mounjaro's success in obesity and T2D. The company is expanding its pipeline with Orforglipron [oral GLP-1 ...

Whether repurposing a song by The Beatles or leveraging the starpower of Academy Award-winner Julianne Moore, Eli Lilly has amplified several ad campaigns focused on Alzheimer’s disease and brain ...